Journal article · 2022 · Open access

Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?

Trishna Bharadia, Jo Vandercappellen, Tanuja Chitnis, Piet Eelen, Birgit Bauer, Giampaolo Brichetto, Andrew J. Lloyd, Hollie K. Schmidt, Miriam King, Jennifer Fitzgerald, Thomas Hach, Jeremy Charles Hobart

Multiple Sclerosis Journal - Experimental Translational and Clinical, 8(2), 20552173221105642 · Published 1 April 2022 · DOI 10.1177/20552173221105642

Open full textCite this paper

In brief

“Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?” is a 2022 journal article by Trishna Bharadia and 11 co-authors, published in Multiple Sclerosis Journal - Experimental Translational and Clinical. OpenAlex counts 13 citations as of 22 November 2026, which puts it in the top 8% of works published in 2022 by citations. It is open access under a CC BY-NC licence: the full text is free to read at Multiple Sclerosis Journal - Experimental Translational and Clinical.

Citations
13
Most cited in
2024 (5)
Field-weighted impact
1.26
References
28
Authors
12

Abstract

Background: Patient-reported outcomes (PROs) are widely measured in multiple sclerosis (MS) studies. However, the quality of instrument development processes varies, raising concerns about the meaningfulness of associated data. Objectives: To review the development of selected PROs commonly used in MS studies, including definitions of the concepts measured, use of conceptual frameworks, and degree of input from people living with MS (PlwMS). To gain insights and recommendations from PlwMS on their experience with these PROs. Methods: We assessed 6 PROs (FSIQ-RMS, modified-FIS, MSQoL-54, Leeds 8-item MSQoL, MSIS-29 and EQ-5D) for alignment with regulatory and scientific requirements on PRO structure/development. PlwMS evaluated the degree to which the PROs reflect disease aspects they perceive important. Results: Definitions, clarifications and conceptualisations of the measurement variables were often lacking. PlwMS were variably involved in PRO development. Ethnic diversity was rarely documented. PlwMS identified individualisation, ease of understanding, time burden, and mode of administration as factors affecting PRO usability. Conclusions: To date, the PRO development process has consistently lacked clear definitions of concepts of interest, use of conceptual frameworks and patient involvement, thereby compromising the validity of data they generate. PRO instrument development must be conducted more robustly to maximise the value of pivotal clinical trials.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Bharadia, T., Vandercappellen, J., Chitnis, T., Eelen, P., Bauer, B., Brichetto, G., Lloyd, A. J., Schmidt, H. K., King, M., Fitzgerald, J., Hach, T., & Hobart, J. C. (2022). Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables? Multiple Sclerosis Journal - Experimental Translational and Clinical, 8(2), 20552173221105642. https://doi.org/10.1177/20552173221105642

MLA 9

Bharadia, Trishna, et al. “Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?” Multiple Sclerosis Journal - Experimental Translational and Clinical, vol. 8, no. 2, 2022, p. 20552173221105642. https://doi.org/10.1177/20552173221105642.

Chicago

Bharadia, Trishna, Jo Vandercappellen, Tanuja Chitnis, Piet Eelen, Birgit Bauer, Giampaolo Brichetto, Andrew J. Lloyd, et al. 2022. “Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?” Multiple Sclerosis Journal - Experimental Translational and Clinical 8 (2): 20552173221105642. https://doi.org/10.1177/20552173221105642.

Harvard

Bharadia, T. et al. (2022) ‘Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?’, Multiple Sclerosis Journal - Experimental Translational and Clinical, 8(2), p. 20552173221105642. doi:10.1177/20552173221105642.

IEEE

T. Bharadia et al., “Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?,” Multiple Sclerosis Journal - Experimental Translational and Clinical, vol. 8, no. 2, p. 20552173221105642, 2022, doi: 10.1177/20552173221105642.

BibTeX

@article{bharadia2022patient,
  title     = {{Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?}},
  author    = {Bharadia, Trishna and Vandercappellen, Jo and Chitnis, Tanuja and Eelen, Piet and Bauer, Birgit and Brichetto, Giampaolo and Lloyd, Andrew J. and Schmidt, Hollie K. and King, Miriam and Fitzgerald, Jennifer and Hach, Thomas and Hobart, Jeremy Charles},
  journal   = {Multiple Sclerosis Journal - Experimental Translational and Clinical},
  year      = {2022},
  volume    = {8},
  number    = {2},
  pages     = {20552173221105642},
  doi       = {10.1177/20552173221105642},
  url       = {https://doi.org/10.1177/20552173221105642}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202322
202455
202533
202633

Its field-weighted citation impact is 1.26: it has been cited 1.26 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies

  • patient-reported outcome measures
  • multiple sclerosis
  • instrument development
  • patient involvement
  • conceptual framework
  • measurement validity
  • MSQOL-54
  • MSIS-29

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Bharadia, T., Vandercappellen, J., Chitnis, T., Eelen, P., Bauer, B., Brichetto, G., Lloyd, A. J., Schmidt, H. K., King, M., Fitzgerald, J., Hach, T., & Hobart, J. C. (2022). Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables? Multiple Sclerosis Journal - Experimental Translational and Clinical, 8(2), 20552173221105642. https://doi.org/10.1177/20552173221105642

How many times has this paper been cited?

13 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Multiple Sclerosis Journal - Experimental Translational and Clinical: sign in and open the full text from this page.

Who wrote this paper?

Trishna Bharadia, Jo Vandercappellen, Tanuja Chitnis, Piet Eelen, Birgit Bauer, Giampaolo Brichetto, Andrew J. Lloyd, Hollie K. Schmidt, Miriam King, Jennifer Fitzgerald, Thomas Hach, Jeremy Charles Hobart.

What is the DOI of this paper?

10.1177/20552173221105642, permanently at https://doi.org/10.1177/20552173221105642. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.